China Universal Asset Management Company’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $264K | Buy |
17,836
+36
| +0.2% | +$533 | 0.02% | 288 |
|
|
2025
Q1 | $319K | Sell |
17,800
-406
| -2% | -$7.28K | 0.03% | 282 |
|
|
2024
Q4 | $317K | Buy |
18,206
+3,494
| +24% | +$60.9K | 0.03% | 292 |
|
|
2024
Q3 | $206K | Buy |
14,712
+5,767
| +64% | +$80.7K | 0.02% | 297 |
|
|
2024
Q2 | $73.5K | Sell |
8,945
-5,707
| -39% | -$46.9K | 0.01% | 321 |
|
|
2024
Q1 | $113K | Buy |
14,652
+5,962
| +69% | +$46K | 0.01% | 362 |
|
|
2023
Q4 | $78.1K | Buy |
8,690
+6,773
| +353% | +$60.9K | 0.02% | 313 |
|
|
2023
Q3 | $17.1K | Buy |
1,917
+939
| +96% | +$8.4K | 0.01% | 309 |
|
|
2023
Q2 | $15K | Buy |
978
+101
| +12% | +$1.55K | ﹤0.01% | 291 |
|
|
2023
Q1 | $19.7K | Buy |
877
+225
| +35% | +$5.06K | 0.01% | 223 |
|
|
2022
Q4 | $13.7K | Buy |
652
+53
| +9% | +$1.12K | 0.01% | 205 |
|
|
2022
Q3 | $15K | Buy |
+599
| New | +$15K | 0.01% | 173 |
|